Literature DB >> 18397837

A novel missense mutation (G43S) in the switch I region of Rab27A causing Griscelli syndrome.

Wendy Westbroek1, Maya Tuchman, Bradford Tinloy, Olivier De Wever, Thierry Vilboux, Jens M Hertz, Henrik Hasle, Carsten Heilmann, Amanda Helip-Wooley, Robert Kleta, William A Gahl.   

Abstract

The autosomal recessive Griscelli syndrome type II (GSII) is caused by mutations in the RAB27A gene. Typical clinical features include immunological impairment, silver-gray scalp hair, eyelashes and eyebrows and hypomelanosis of the skin. Rabs help determine the specificity of membrane trafficking steps within cells. In melanocytes, the GTP-bound form of Rab27A associates with the membranes of mature fully-pigmented melanosomes through its geranylgeranyl group. Once attached, Rab27A recruits the downstream effector Melanophilin (Mlph) and the actin-dependent motor protein Myosin Va (MyoVa). The molecular Rab27A/Mlph/MyoVA tripartite complex, which links melanosomes to the peripheral actin network, is required to achieve melanosome transfer to surrounding keratinocytes in the epidermis. Here we report a novel homozygous missense mutation c.127G>A, p.G43S in exon 2 of the RAB27A gene of an Afghani GSII patient. Laser scanning confocal microscopy showed that the G43S mutation, which is located in the highly conserved switch I region of Rab27A, induces perinuclear localization of melanosomes in normal melanocytes, and fails to restore melanosomes to the actin-rich periphery in GSII melanocytes. Co-immunoprecipitation studies showed that Rab27A(G43S) fails to interact with its effector Melanophilin, indicating that the switch I region functions in the recruitment of Rab effector proteins.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18397837      PMCID: PMC2430933          DOI: 10.1016/j.ymgme.2008.02.009

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  41 in total

1.  Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome.

Authors:  G Ménasché; E Pastural; J Feldmann; S Certain; F Ersoy; S Dupuis; N Wulffraat; D Bianchi; A Fischer; F Le Deist; G de Saint Basile
Journal:  Nat Genet       Date:  2000-06       Impact factor: 38.330

2.  Identification of an organelle receptor for myosin-Va.

Authors:  Xufeng S Wu; Kang Rao; Hong Zhang; Fei Wang; James R Sellers; Lydia E Matesic; Neal G Copeland; Nancy A Jenkins; John A Hammer
Journal:  Nat Cell Biol       Date:  2002-04       Impact factor: 28.824

3.  Rab27a is an essential component of melanosome receptor for myosin Va.

Authors:  Xufeng Wu; Fei Wang; Kang Rao; James R Sellers; John A Hammer
Journal:  Mol Biol Cell       Date:  2002-05       Impact factor: 4.138

4.  Mutations in Mlph, encoding a member of the Rab effector family, cause the melanosome transport defects observed in leaden mice.

Authors:  L E Matesic; R Yip; A E Reuss; D A Swing; T N O'Sullivan; C F Fletcher; N G Copeland; N A Jenkins
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

Review 5.  Thematic review series: lipid posttranslational modifications. geranylgeranylation of Rab GTPases.

Authors:  Ka Fai Leung; Rudi Baron; Miguel C Seabra
Journal:  J Lipid Res       Date:  2006-01-09       Impact factor: 5.922

6.  Slac2-a/melanophilin, the missing link between Rab27 and myosin Va: implications of a tripartite protein complex for melanosome transport.

Authors:  Mitsunori Fukuda; Taruho S Kuroda; Katsuhiko Mikoshiba
Journal:  J Biol Chem       Date:  2002-02-20       Impact factor: 5.157

7.  Evidence that Griscelli syndrome with neurological involvement is caused by mutations in RAB27A, not MYO5A.

Authors:  Yair Anikster; Marjan Huizing; Paul D Anderson; Diana L Fitzpatrick; Aharon Klar; Eva Gross-Kieselstein; Yackov Berkun; Gila Shazberg; William A Gahl; Haggit Hurvitz
Journal:  Am J Hum Genet       Date:  2002-06-07       Impact factor: 11.025

8.  Rab27a enables myosin Va-dependent melanosome capture by recruiting the myosin to the organelle.

Authors:  X Wu; K Rao; M B Bowers; N G Copeland; N A Jenkins; J A Hammer
Journal:  J Cell Sci       Date:  2001-03       Impact factor: 5.285

9.  Rab27a is required for regulated secretion in cytotoxic T lymphocytes.

Authors:  J C Stinchcombe; D C Barral; E H Mules; S Booth; A N Hume; L M Machesky; M C Seabra; G M Griffiths
Journal:  J Cell Biol       Date:  2001-02-19       Impact factor: 10.539

10.  Rab27a: A key to melanosome transport in human melanocytes.

Authors:  P Bahadoran; E Aberdam; F Mantoux; R Buscà; K Bille; N Yalman; G de Saint-Basile; R Casaroli-Marano; J P Ortonne; R Ballotti
Journal:  J Cell Biol       Date:  2001-02-19       Impact factor: 10.539

View more
  11 in total

1.  Cellular and clinical report of new Griscelli syndrome type III cases.

Authors:  Wendy Westbroek; Aharon Klar; Andrew R Cullinane; Shira G Ziegler; Haggit Hurvitz; Ashraf Ganem; Kirkland Wilson; Heidi Dorward; Marjan Huizing; Haled Tamimi; Igor Vainshtein; Yackov Berkun; Moran Lavie; William A Gahl; Yair Anikster
Journal:  Pigment Cell Melanoma Res       Date:  2011-10-03       Impact factor: 4.693

2.  Mutation analysis and prenatal diagnosis of a family with Griscelli syndrome type 2: two novel mutations in the RAB27A gene.

Authors:  Patra Yeetong; Kanya Suphapeetiporn; Vorasuk Shotelersuk
Journal:  World J Pediatr       Date:  2017-08       Impact factor: 2.764

3.  Effect of the secretory small GTPase Rab27B on breast cancer growth, invasion, and metastasis.

Authors:  An Hendrix; Dawn Maynard; Patrick Pauwels; Geert Braems; Hannelore Denys; Rudy Van den Broecke; Jo Lambert; Simon Van Belle; Veronique Cocquyt; Christian Gespach; Marc Bracke; Miguel C Seabra; William A Gahl; Olivier De Wever; Wendy Westbroek
Journal:  J Natl Cancer Inst       Date:  2010-05-18       Impact factor: 13.506

4.  Overexpression of Rab27B is correlated with distant metastasis and poor prognosis in ovarian cancer.

Authors:  Ping Ren; Xiao-Qing Yang; Xiao-Lu Zhai; Yu-Quan Zhang; Jian-Fei Huang
Journal:  Oncol Lett       Date:  2016-06-29       Impact factor: 2.967

5.  An Indian boy with griscelli syndrome type 2: case report and review of literature.

Authors:  Ankur Singh; Amit Garg; Seema Kapoor; Nita Khurana; Miriam Entesarian; Bianca Tesi
Journal:  Indian J Dermatol       Date:  2014-07       Impact factor: 1.494

6.  The secretory small GTPase Rab27B as a marker for breast cancer progression.

Authors:  An Hendrix; Geert Braems; Marc Bracke; Miguel Seabra; William Gahl; Olivier De Wever; Wendy Westbroek
Journal:  Oncotarget       Date:  2010-08

7.  Synaptotagmin-Like Protein 2a Regulates Angiogenic Lumen Formation via Weibel-Palade Body Apical Secretion of Angiopoietin-2.

Authors:  Caitlin R Francis; Shea Claflin; Erich J Kushner
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-04-15       Impact factor: 10.514

8.  Overexpression of the secretory small GTPase Rab27B in human breast cancer correlates closely with lymph node metastasis and predicts poor prognosis.

Authors:  Jia-Xing Zhang; Xiao-Xia Huang; Man-Bo Cai; Zhu-Ting Tong; Jie-Wei Chen; Dong Qian; Yi-Ji Liao; Hai-Xia Deng; Ding-Zhun Liao; Ma-Yan Huang; Yi-Xin Zeng; Dan Xie; Shi-Juan Mai
Journal:  J Transl Med       Date:  2012-12-05       Impact factor: 5.531

9.  Human liver cell trafficking mutants: characterization and whole exome sequencing.

Authors:  Fei Yuan; Erik L Snapp; Phyllis M Novikoff; Sylvia O Suadicani; David C Spray; Barry Potvin; Allan W Wolkoff; Pamela Stanley
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

10.  Canine hereditary ataxia in old english sheepdogs and gordon setters is associated with a defect in the autophagy gene encoding RAB24.

Authors:  Caryline Agler; Dahlia M Nielsen; Ganokon Urkasemsin; Andrew Singleton; Noriko Tonomura; Snaevar Sigurdsson; Ruqi Tang; Keith Linder; Sampath Arepalli; Dena Hernandez; Kerstin Lindblad-Toh; Joyce van de Leemput; Alison Motsinger-Reif; Dennis P O'Brien; Jerold Bell; Tonya Harris; Steven Steinberg; Natasha J Olby
Journal:  PLoS Genet       Date:  2014-02-06       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.